01:06 AM EDT, 10/22/2026 (MT Newswires) -- Galenica (GALE.SW) logged a year-over-year growth in group net sales for the first nine months of 2026, a Thursday filing showed. For the nine months ended Sept. 30, group net sales stood at 3.17 billion francs versus 3 billion francs previously, the Swiss pharmaceutical and logistics company added. For full-year 2026, the company reiterated its sales growth guidance of between 5% and 7%. The company also plans to pay a dividend at least similar to the 2025 level.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.